Dec 8 (Reuters) - Halix B.V:
* DGAP-NEWS: HALIX B.V.: HALIX SIGNS AGREEMENT WITH ASTRAZENECA FOR COMMERCIAL MANUFACTURE OF COVID-19 VACCINE
* HALIX B.V. - SIGNED AN AGREEMENT WITH ASTRAZENECA AB FOR LARGE-SCALE COMMERCIAL DRUG SUBSTANCE MANUFACTURE OF AZD1222
* HALIX - UNDER DEAL, CO TO PROVIDE COMMERCIAL MANUFACTURING OF DRUG SUBSTANCE AT CGMP FACILITY IN NETHERLANDS Source text for Eikon: Further company coverage:
Read Again https://www.reuters.com/article/brief-halix-signs-deal-with-astrazeneca/brief-halix-signs-deal-with-astrazeneca-for-commercial-manufacture-of-covid-19-vaccine-idUSASN000M07Bagikan Berita Ini
Related Posts :
AI-focused manufacturing startup raises $106 million, from Nvidia and others - Yahoo Finance- NorSun Plans $620M Investment in Oklahoma for U.S. Solar Wafer Manufacturing Operations - Oklahoma Department of Commerce
- San Diego's Dexcom cuts 500 jobs, moves manufacturing to Arizona - The San Diego Union-Tribune
- Ozempic craze: Novo Nordisk invests $4.1B in US to expand manufacturing - Fox Business
- For American Brands Worried About China, Is India the Future? - The New York Times
0 Response to "BRIEF-Halix Signs Deal With Astrazeneca For Commercial Manufacture Of COVID-19 Vaccine - Reuters"
Post a Comment